Immuneering has announced median survival data from its ongoing pancreatic cancer trial. The company is actively researching this significant area within oncology.
Immuneering is a company involved in oncology research, specifically focusing on pancreatic cancer trials. The release of median survival data is a key event in the progression of such clinical studies.
Immuneering is a company involved in oncology research, specifically focusing on pancreatic cancer trials. The release of median survival data is a key event in the progression of such clinical studies.
Pick the topics you care about. Get only what matters, on your cadence.